secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001493152-23-020378
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies stockholders approve increase in authorized shares to 25M and equity plan shares to 2M
--------------------------------------------------------------------------------

- Authorized common shares increased from 14,285,715 to 25,000,000 via Certificate of Amendment filed June 6, effective June 7, 2023.
- Equity Incentive Plan share reserve increased from 1,142,857 to 2,000,000; plan became effective June 6, 2023.
- All seven director nominees elected; WithumSmith+Brown ratified as independent auditor for FY2023.
- Annual meeting quorum achieved with 6,433,619 votes representing 75.43% of voting power.
- Share increase and plan amendment both received affirmative votes from a majority of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223020378/0001493152-23-020378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223020378/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer